Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wildemann

Showing results (131-140 of 204) with videos related to

Pageof 21
Sort By:
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Journal of Neurochemistry|March 18, 2021
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignanciesDominic Schmid, Uwe Warnken, Pauline Latzer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum DisordersMoritz Niederschweiberer, Georgia Panagiotaropoulou, Marcelo A Fernandez-Viña, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2017
Diagnostic criteria for Susac syndromeIlka Kleffner, Jan Dörr, Marius Ringelstein, et al.
European Journal of Neurology|January 10, 2021
Pain, depression, and quality of life in adults with MOG-antibody-associated diseaseSusanna Asseyer, Eugenia Henke, Corinna Trebst, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 31, 2014
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disordersFelipe von Glehn, Sven Jarius, Rodrigo Pessoa Cavalcanti Lira, et al.
Science Immunology|September 27, 2024
Twin study identifies early immunological and metabolic dysregulation of CD8<sup>+</sup> T cells in multiple sclerosisVladyslav Kavaka, Luisa Mutschler, Clara de la Rosa Del Val, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.
Journal of Neurology|April 5, 2024
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Pageof 21

Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Journal of Neurochemistry|March 18, 2021
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignanciesDominic Schmid, Uwe Warnken, Pauline Latzer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum DisordersMoritz Niederschweiberer, Georgia Panagiotaropoulou, Marcelo A Fernandez-Viña, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2017
Diagnostic criteria for Susac syndromeIlka Kleffner, Jan Dörr, Marius Ringelstein, et al.
European Journal of Neurology|January 10, 2021
Pain, depression, and quality of life in adults with MOG-antibody-associated diseaseSusanna Asseyer, Eugenia Henke, Corinna Trebst, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 31, 2014
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disordersFelipe von Glehn, Sven Jarius, Rodrigo Pessoa Cavalcanti Lira, et al.
Science Immunology|September 27, 2024
Twin study identifies early immunological and metabolic dysregulation of CD8<sup>+</sup> T cells in multiple sclerosisVladyslav Kavaka, Luisa Mutschler, Clara de la Rosa Del Val, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.
Journal of Neurology|April 5, 2024
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Pageof 21